Delaying reperfusion plus left ventricular unloading reduces infarct size: Sub-analysis of DTU-STEMI pilot study

医学 传统PCI 心脏病学 经皮冠状动脉介入治疗 内科学 罪魁祸首 心肌梗塞 扬抑 蒂米 动脉
作者
Navin K. Kapur,Mohit Pahuja,Ajar Kochar,Richard H. Karas,James E. Udelson,Jeffrey W. Moses,Gregg W. Stone,Nima Aghili,Haroon Faraz,William W. O’Neill
出处
期刊:Cardiovascular Revascularization Medicine [Elsevier]
卷期号:60: 11-17 被引量:6
标识
DOI:10.1016/j.carrev.2023.09.009
摘要

The STEMI-DTU pilot study tested the early safety and practical feasibility of left ventricular (LV) unloading with a trans-valvular pump before reperfusion. In the intent-to-treat cohort, no difference was observed for microvascular obstruction (MVO) or infarct size (IS) normalized to either the area at risk (AAR) at 3–5 days or total LV mass (TLVM) at 3–5 days We now report a per protocol analysis of the STEMI-DTU pilot study. In STEMI-DTU STUDY 50 adult patients (25 in each arm) with anterior STEMI [sum of precordial ST-segment elevation (ΣSTE) ≥4 mm] requiring primary percutaneous coronary intervention (PCI) were enrolled. Only patients who met all inclusion and exclusion criteria were included in this analysis. Cardiac magnetic resonance (CMR) imaging 3–5 days after PCI quantified IS/AAR and IS/TLVM and MVO. Group differences were assessed using Student's t-tests and linear regression (SAS Version-9.4). Of the 50 patients enrolled, 2 died before CMR imaging. Of the remaining 48 patients those without CMR at 3–5 days (n = 8), without PCI of a culprit left anterior descending artery lesion (n = 2), with OHCA (n = 1) and with ΣSTE < 4 mm (n = 5) were removed from this analysis leaving 32/50 (64 %) patients meeting all inclusion and exclusion criteria (U-IR, n = 15; U-DR, n = 17) as per protocol. Despite longer symptom-to-balloon times in the U-DR arm (228 ± 80 vs 174 ± 59 min, p < 0.01), IS/AAR was significantly lower with 30 min of delay to reperfusion in the presence of active LV unloading (47 ± 16 % vs 60 ± 15 %, p = 0.02) and remained lower irrespective of the magnitude of precordial ΣSTE. MVO was not significantly different between groups (1.5 ± 2.8 % vs 3.5 ± 4.8 %, p = 0.15). Among patients who received LV unloading within 180 min of symptom onset, IS/AAR was significantly lower in the U-DR group. In this per-protocol analysis of the STEMI-DTU pilot study we observed that LV unloading for 30 min before reperfusion significantly reduced IS/AAR compared to LV unloading and immediate reperfusion, whereas in the ITT cohort no difference was observed between groups. This observation supports the design of the STEMI-DTU pivotal trial and suggests that strict adherence to the study protocol can significantly influence the outcome.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhaihaixu发布了新的文献求助10
刚刚
传奇3应助Benjamin采纳,获得30
刚刚
白蓝发布了新的文献求助10
1秒前
1秒前
liu发布了新的文献求助10
2秒前
3秒前
尚秋月完成签到,获得积分10
3秒前
piedpiper完成签到,获得积分10
3秒前
快乐乐松发布了新的文献求助10
4秒前
负责啤酒完成签到,获得积分10
4秒前
超级天川发布了新的文献求助10
4秒前
Shuhe_Gong完成签到 ,获得积分10
5秒前
慕青应助着急的笑旋采纳,获得10
5秒前
橙子完成签到,获得积分10
6秒前
量子星尘发布了新的文献求助10
7秒前
蛐蛐儿完成签到,获得积分10
7秒前
8秒前
LBQ完成签到,获得积分10
8秒前
领导范儿应助123采纳,获得10
8秒前
爆米花应助科研通管家采纳,获得10
9秒前
9秒前
852应助科研通管家采纳,获得20
9秒前
asdfzxcv应助科研通管家采纳,获得10
9秒前
浮游应助科研通管家采纳,获得10
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
CipherSage应助科研通管家采纳,获得10
9秒前
初心路完成签到 ,获得积分10
9秒前
浮游应助科研通管家采纳,获得10
9秒前
小二郎应助科研通管家采纳,获得10
9秒前
马龙完成签到,获得积分10
9秒前
asdfzxcv应助科研通管家采纳,获得10
9秒前
田様应助科研通管家采纳,获得10
9秒前
浮游应助科研通管家采纳,获得10
9秒前
浮游应助科研通管家采纳,获得10
10秒前
无花果应助科研通管家采纳,获得10
10秒前
科研通AI6应助科研通管家采纳,获得10
10秒前
zhu完成签到,获得积分20
10秒前
bkagyin应助科研通管家采纳,获得10
10秒前
情怀应助科研通管家采纳,获得10
10秒前
浮游应助科研通管家采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
From Victimization to Aggression 1000
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Exosomes Pipeline Insight, 2025 500
Red Book: 2024–2027 Report of the Committee on Infectious Diseases 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5652693
求助须知:如何正确求助?哪些是违规求助? 4787996
关于积分的说明 15061272
捐赠科研通 4811158
什么是DOI,文献DOI怎么找? 2573692
邀请新用户注册赠送积分活动 1529549
关于科研通互助平台的介绍 1488312